Revenue - Genovis AB (STO:GENO) - Alpha Spread
G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 22.75 SEK 0.22% Market Closed
Market Cap: 1.5B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genovis AB
Revenue Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Revenue
kr127m
CAGR 3-Years
22%
CAGR 5-Years
24%
CAGR 10-Years
30%
AddLife AB
STO:ALIF B
Revenue
kr9.7B
CAGR 3-Years
22%
CAGR 5-Years
31%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Revenue
kr2.2B
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Revenue
kr2.1B
CAGR 3-Years
22%
CAGR 5-Years
16%
CAGR 10-Years
16%
MedCap AB (publ)
STO:MCAP
Revenue
kr1.7B
CAGR 3-Years
27%
CAGR 5-Years
19%
CAGR 10-Years
7%
M
Magle Chemoswed Holding AB
STO:MAGLE
Revenue
kr170.4m
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is Genovis AB's Revenue?
Revenue
127m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Revenue amounts to 127m SEK.

What is Genovis AB's Revenue growth rate?
Revenue CAGR 10Y
30%

Over the last year, the Revenue growth was -15%. The average annual Revenue growth rates for Genovis AB have been 22% over the past three years , 24% over the past five years , and 30% over the past ten years .

Back to Top